Page 10 - Codexis Inc News Today

Codexis (NASDAQ:CDXS – Get Free Report) was downgraded by stock analysts at TD Cowen from an “outperform” rating to a “market perform” rating in a report issued on Monday, Marketbeat reports. They currently have a $4.00 price objective on the biotechnology company’s stock, down from their prior price objective of $21.00. TD Cowen’s price objective […]

BlackRock Inc. (Trades, Portfolio), a leading global investment management corporation, has recently increased its stake in Codexis Inc., a prominent player in the biotechnology industry. This article provides an in-depth analysis of the transaction, profiles of both BlackRock Inc. (Trades, Portfolio) and Codexis Inc., and an examination of Codexis Inc.'s financial health and stock performance.

Codexis (NASDAQ:CDXS – Get Free Report) and LanzaTech Global (NASDAQ:LNZA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Insider & Institutional Ownership 88.0% of Codexis shares […]

Codexis (NASDAQ:CDXS – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.04, Briefing.com reports. Codexis had a negative net margin of 41.17% and a negative return on equity of 32.75%. The company had revenue of […]

Codexis (NASDAQ:CDXS – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.04, Briefing.com reports. Codexis had a negative net margin of 41.17% and a negative return on equity of 32.75%. The company had revenue of […]

These five stocks that Cathie Wood's ARK funds own millions of shares of are perfect for aggressive investors who look to get share count leverage on companies that have sizable upside potential.

Codexis (NASDAQ:CDXS – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.04, Briefing.com reports. The firm had revenue of $21.32 million for the quarter, compared to analysts’ expectations of $19.83 million. Codexis had a negative net margin of […]

New Film Highlights Company Commitment to Transforming RNAi Therapeutics Landscape REDWOOD CITY, Calif., July 31, 2023 -- Codexis, Inc. (NASDAQ: CDXS),...

Investing in small companies, penny stocks, micro-cap or even small-cap companies went out of fashion as soon as the financial markets started to take a beating amid interest rate hikes.

In this article, we will take a look at the 10 best rated penny stocks to buy according to analysts. To see more such companies, go directly to 5 Best Rated Penny Stocks to Buy According to Analysts. Investing in small companies, penny stocks, micro-cap or even small-cap companies went out of fashion as soon […]